B. Meng

发表

Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established

M. Carroll, N. Dimmock, A. Easton, 2012, PloS one.

Defective interfering virus protects elderly mice from influenza

N. Dimmock, A. Easton, A. Marriott, 2011, Virology Journal.

Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease

Steven F. Baker, Kenneth G. C. Smith, J. Briggs, 2020 .

The Interplay between ESCRT and Viral Factors in the Enveloped Virus Life Cycle

B. Meng, A. Lever, 2021, Viruses.

The receptor preference of influenza viruses

N. Dimmock, A. Marriott, B. Meng, 2010, Influenza and other respiratory viruses.

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir

M. Carroll, N. Dimmock, A. Easton, 2012, Antiviral research.

Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus.

N. Dimmock, A. Easton, A. Marriott, 2011, The Journal of general virology.

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Frances E. Muldoon, Kenneth G. C. Smith, Eleanor F. Dewhurst, 2022, Nature.

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion

Ravindra K. Gupta, Kei Sato, A. Takaori-Kondo, 2021, The Journal of infectious diseases.

SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity

B. Meng, J. Bradley, Jinwook Choi, 2022, bioRxiv.

Brief Report Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease.

Steven F. Baker, Nikos, Myra, 2020 .

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

William T. Harvey, Kenneth G. C. Smith, A. Walls, 2021, medRxiv : the preprint server for health sciences.

Kenneth G. C. Smith, R. Döffinger, M. Wills, 2021 .

Kenneth G. C. Smith, M. Wills, P. Lyons, 2021 .

Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

Steven F. Baker, Kenneth G. C. Smith, N. Walker, 2020, Cell Reports Medicine.

Combined point of care nucleic acid and antibody testing for SARS-CoV-2: a prospective cohort study in suspected moderate to severe COVID-19 disease.

S. Baker, J. Briggs, A. Ritchie, 2020, medRxiv.

Frances E. Muldoon, Sarah E. Jackson, Kenneth G. C. Smith, 2021, Nature.

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

S. Bhatt, S. Flaxman, Raju Vaishya, 2021, Nature.

Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo

N. Dimmock, A. Easton, A. Marriott, 2011, Vaccine.

A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.

Nicole L Edworthy, N. Dimmock, A. Easton, 2011, Vaccine.

SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough

S. Bhatt, S. Flaxman, Raju Vaishya, 2021 .

Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

William T. Harvey, Kenneth G. C. Smith, A. Walls, 2021, Nature.

SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies

Kenneth G. C. Smith, A. Walls, D. Veesler, 2021 .

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

William T. Harvey, D. Robertson, L. James, 2020, bioRxiv.

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift

Kenneth G. C. Smith, J. Briggs, A. Sigal, 2022, bioRxiv.

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

William T. Harvey, Graham W. Taylor, William L. Hamilton, 2021, Cell Reports.

M. Wills, P. Lyons, E. McKinney, 2021, medRxiv.

Delta variant emergence , replication and sensitivity to 1 neutralising antibodies 2 3

William L. Hamilton, S. Bhatt, S. Flaxman, 2021 .

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

N. Dimmock, A. Easton, A. Marriott, 2017, Virology Journal.

Wrapping up the bad news – HIV assembly and release

Bo Meng, Andrew ML Lever, B. Meng, 2013, Retrovirology.

EAP45 association with budding HIV‐1: Kinetics and domain requirements

Pedro P. Vallejo Ramirez, C. Kaminski, Katharina M. Scherer, 2021, Traffic.

Distinct domain requirements for EAP45 in HIV budding, late endosomal recruitment, and cytokinesis

Pedro P. Vallejo Ramirez, C. Kaminski, Katharina M. Scherer, 2020, bioRxiv.

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Graham W. Taylor, William L. Hamilton, Joshua B. Singer, 2021, Nature.

ESCRT‐II functions by linking to ESCRT‐I in human immunodeficiency virus‐1 budding

B. Meng, A. Lever, Natasha C Y Ip, 2020, Cellular Microbiology.

SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion

L. James, Ravindra K. Gupta, P. Mlcochova, 2021 .

Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2

R. Doffinger, N. Kingston, B. Meng, 2021, medRxiv.

Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production

B. Meng, A. Lever, Natasha C Y Ip, 2015, Retrovirology.

SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS 2-dependent viral 1 entry and fusogenicity 2 3

Bradley, B. Meng, Jinwook Choi, 2022 .

Proceedings of the Frontiers of Retrovirology Conference 2016

Sebastian A. Wagner, R. König, D. Elleder, 2016, Retrovirology.

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough

William L. Hamilton, S. Bhatt, S. Flaxman, 2021 .

Emergence of a novel reassortant H3N6 canine influenza virus

Haiyang Li, Hualan Chen, B. Meng, 2023, Frontiers in Microbiology.

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough

William L. Hamilton, S. Bhatt, S. Flaxman, 2021, bioRxiv.